With SI n n(%) | Without SI n | χ2/t | p | Effect size (φ/Cohen’s d) | ||||
---|---|---|---|---|---|---|---|---|
Comorbid substance use, n(%) | Yes | 54 | 21 (38.8) | 246 | 61 (24.8) | 4.42 | 0.043* | 0.12 |
No | 33 (61.1) | 185 (75.2) | ||||||
Comorbid tobacco use, n(%) | Yes | 54 | 21 (38.8) | 246 | 58(23.5) | 5.35 | 0.026* | 0.13 |
No | 33 (61.1) | 188(76.4) | ||||||
Family history of suicide/attempt, n(%) | Yes | 54 | 10 (18.5) | 246 | 35 (14.2) | 0.63 | 0.52 | - |
No | 44 (81.5) | 211 (85.8) | ||||||
Comorbid physical illness, n(%) | Yes | 54 | 14(26) | 246 | 69(28) | 0.1 | 0.86 | - |
No | 40(74) | 177(72) | ||||||
ECTs received, n(%) | Yes | 54 | 17 (31.5) | 246 | 42 (17.1) | 5.8 | 0.02* | 0.13 |
No | 37 (68.5) | 204 (82.9) | ||||||
Current comorbid depression, n(%) | Yes | 54 | 20 (37) | 244 | 20 (8.2) | 31.6 | < 0.001* | 0.32 |
No | 34 (63 | 224(91.8) | ||||||
Lifetime depressive episode, n(%) | Yes | 54 | 26 (48.1) | 243 | 32(13.2) | 34.4 | 0.38 | 0.34 |
No | 28 (51.9) | 211 (86.8) | ||||||
Type of antipsychotic, n(%) | FGA | 54 | 1(1.9) | 246 | 14(5.7) | 1.27 | 0.5 | - |
SGA | 40(74.1) | 181(73.6) | ||||||
Both | 13(24.1) | 51(20.7) | ||||||
Compliance to treatment, n(%) | Poor | 54 | 44 (81.5) | 245 | 139 (56.7) | 11.4 | 0.001* | 0.19 |
Good | 10 (18.5) | 106 (43.3) | ||||||
Total antipsychotic dose (CPZ equivalent, mg/day), mean (SD) | 53 | 452.2 (361.9) | 243 | 373.9 (223.3) | 2.03 | 0.04* | 0.26 |